André Manuel da Silva Lopes

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

André Manuel da Silva Lopes is an author at University of Lausanne specializing in immune checkpoint inhibitor care, pharmacy, and patient-reported adverse event capture.

ORCID

Publications per year

2021–2023

Publications

Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study

André Manuel da Silva Lopes, Sara Colomer‐Lahiguera, Nuria Mederos Alfonso et al. · European Journal of Cancer · 2021 · 24 citations · Full text

Pharmacy, Immunology, Oncology +17

Patient and public involvement in research: Reflections and experiences of doctoral cancer nurse researchers in Europe

Mary Anne Tanay, Celia Díez de los Ríos de la Serna, Vanessa Boland et al. · European Journal of Oncology Nursing · 2023 · 17 citations · Full text

Nursing, Oncology Nursing, Clinical Medicine +15

Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors

André Manuel da Silva Lopes, Sara Colomer‐Lahiguera, Célia Darnac et al. · Supportive Care in Cancer · 2023 · 14 citations · Full text

Pharmacy, Biomedical Informatics, Health Informatics +17

1–3 of 3